2
项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的临床试验An Exploratory Study on the Use of Intranasal Administration of Small Extracellular Vesicles for the Treatment of Amyotrophic Lateral Sclerosis
This is a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of nasal drop exosomes derived from human umbilical cord blood mesenchymal stem cells (hUC-MSC-sEV-001) in amyotrophic lateral sclerosis.
A Multi-center, Open, Single-arm, Basket-design Clinical Trial to Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles HUC-MSC-sEV-001 Nasal Drops for the Treatment of Multiple Neurodegenerative Diseases
To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, and frontotemporal dementia.
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的临床结果
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的转化医学
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的专利(医药)
100 项与 HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital ) 相关的药物交易